Lei Y, Sehnert B, Voll RE, Jacobs-Cacha C, et al. A multicenter blinded preclinical randomized controlled trial on Jak1/2 inhibition in MRL/MpJ-Fas(lpr) mice with proliferative lupus nephritis predicts low effect size. Kidney Int 2021 Feb 16. pii: S0085-2538(21)00205.
PMID: 33607177